DEUTSCHE BANK AG\ - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 15 filers reported holding AKARI THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$1,000
-99.6%
1,027
-99.2%
0.00%
Q2 2019$266,000
+291.2%
132,000
+594.7%
0.00%
Q1 2019$68,000
+423.1%
19,000
+493.8%
0.00%
Q4 2017$13,000
-59.4%
3,200
-39.6%
0.00%
Q3 2017$32,000
+433.3%
5,300
+278.6%
0.00%
Q2 2017$6,000
-97.7%
1,400
-94.0%
0.00%
Q1 2017$258,000
+57.3%
23,3870.0%0.00%
Q4 2016$164,000
-17.6%
23,3870.0%0.00%
Q3 2016$199,000
-36.8%
23,3870.0%0.00%
Q2 2016$315,000
+34.0%
23,3870.0%0.00%
Q1 2016$235,000
-17.8%
23,387
+18.2%
0.00%
Q4 2015$286,00019,7870.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q2 2017
NameSharesValueWeighting ↓
VHCP Management II, LLC 426,297$1,965,0000.78%
Vivo Capital, LLC 527,842$2,433,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 818,158$3,772,0000.20%
NEA Management Company, LLC 452,167$2,084,0000.08%
Hikari Power Ltd 60,012$277,0000.04%
Baker Brothers Advisors 496,901$2,291,0000.02%
QVT Financial LP 132,077$531,0000.01%
MILLENNIUM MANAGEMENT LLC 214,126$987,0000.00%
Virtu KCG Holdings LLC 12,472$57,0000.00%
Advisor Group, Inc. 6,381$29,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders